Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Acasti Pharma Inc.

NASDAQ: ACSTHealthcare / Biotechnology / Canada
1.10+0.0100+0.92%Vol 203 2641Y Perf 0.50%
Jan 17th, 2019 16:00
BID1.08 ASK1.10
Open1.06 Previous Close1.09
Pre-Market- After-Trading1.10
 - -%  - -%
Target Price
5.37 
Analyst Rating
Strong Buy 1.43
Potencial %
388.18 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★+     41.31
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)86 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
48.91 
Earnings Date
12th Feb 2019

Today's Price Range

1.051.10

 

52wk Range

0.43001.80

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
59.42%
3 Months
-1.79%
6 Months
96.43%
1 Year
0.50%
3 Years
-32.52%
5 Years
-92.20%

Quotes

Name / TickerPriceChg.Chg.%
ACST1.100.01000.92
AAPL155.860.92000.59
GOOG1 089.908.93000.83
MSFT106.120.74000.70
XOM72.130.49000.68
WFC49.230.29000.59
JNJ129.091.05000.82
FB148.300.76000.52
GE9.140.16001.78
JPM102.920.42000.41
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.50
Current Ratio
0.60
Long Term Debt to Total Capital
0.18
Total Debt to Equity
0.22
Interest Coverage
-276.30
Leverage Ratio -3.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-162.30
EBIT Margin
-34 664.40
EBITDA Margin
-25 968.80
Pre-tax Profit Margin
-7 486.20
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
13.67
PS Ratios
22 959.00
Price to Cash Flow
-
Price to Free Cash Flow
-6.90
Cash Flow Per Share
-0.77
Price to Tangible Book
-7.96
Book Value per Share
-0.14
Enterprise Value (in ths.)
85 842
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-43.02
ROE last 12 Months
492 989.00
Return on Assets (5Y Avg)
-52.76
ROA last 12 Months
-223.65
Return on Capital (5Y Avg)
-31.80
ROC last 12 Months
-139.65
Return on invested Capital Q
-77.39
Return on invested Capital Y
-130.01
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-77.66
Revenue Growth 5 Years
-64.51
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q02 2019-0.21-0.204.76
Q04 2017-0.31-0.310.00
Q01 2017--0.23-
Q04 2016--0.13-
Q03 2016--0.16-
Q02 2016--0.01-
Q01 2016--0.01-
Q04 2015--0.02-
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.0846.67Positive
3/2019 QR-0.0846.67Positive
3/2019 FY-0.5422.86Positive
3/2020 FY-0.2629.73Positive
Next Report Date12th Feb 2019
Estimated EPS Next Report-0.08
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume203 264
Shares Outstanding (in ths.)78 130
Trades Count375
Dollar Volume199 684
Avg. Volume516 833
Avg. Weekly Volume406 878
Avg. Monthly Volume508 625
Avg. Quarterly Volume646 779

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

62%38%

Bearish Bullish

57%43%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.43
Strong Buy
1.43
Strong Buy
1.43

There are no comments yet.

News